AJG vs FATE · P/E 33, rev $8.76B vs rev $3.4M
Arthur J Gallagher & Co (AJG) versus Fate Therapeutics Inc (FATE) — a side-by-side from cached financials, not a winner call.
Arthur J Gallagher & Co (AJG) is a insurance brokers company listed on US.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Latest reported AJG revenue for 2026-06-30 was $8.76B. Net income was $1.15B. Revenue was up 84.1% from 2026-03-31 to 2026-06-30. AJG currently screens at market cap $52.03B and trailing P/E 32.8.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
AJG currently screens at market cap $52.03B and trailing P/E 32.8. FATE currently screens at market cap $331.0M.
Not investment advice. Open the AJG and FATE stock pages for the full models.
Not investment advice.